title: Pretransplant imatinib can improve the outcome of nonmyeloablative stem cell transplantation without increasing the morbidity in Philadelphia chromosome-positive chronic myeloid leukemia.
authors.forename: D-W
authors.initials: DW
authors.lastname: Kim
authors.forename: Y-J
authors.initials: YJ
authors.lastname: Chung
authors.forename: S
authors.initials: S
authors.lastname: Lee
authors.forename: Y-J
authors.initials: YJ
authors.lastname: Kim
authors.forename: N-G
authors.initials: NG
authors.lastname: Chung
authors.forename: J A
authors.initials: JA
authors.lastname: Kim
authors.forename: I-H
authors.initials: IH
authors.lastname: Oh
authors.forename: T-G
authors.initials: TG
authors.lastname: Kim
authors.forename: Y-L
authors.initials: YL
authors.lastname: Kim
authors.forename: H-G
authors.initials: HG
authors.lastname: Goh
authors.forename: S-H
authors.initials: SH
authors.lastname: Kim
authors.forename: B
authors.initials: B
authors.lastname: Cho
authors.forename: H-J
authors.initials: HJ
authors.lastname: Kim
authors.forename: C-K
authors.initials: CK
authors.lastname: Min
authors.forename: J W
authors.initials: JW
authors.lastname: Lee
authors.forename: J Y
authors.initials: JY
authors.lastname: Jin
authors.forename: C-W
authors.initials: CW
authors.lastname: Han
authors.forename: J W
authors.initials: JW
authors.lastname: Kim
authors.forename: W-S
authors.initials: WS
authors.lastname: Min
authors.forename: H-K
authors.initials: HK
authors.lastname: Kim
authors.forename: C-C
authors.initials: CC
authors.lastname: Kim
authors.forename: H J
authors.initials: HJ
authors.lastname: Kim
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009017:Morbidity; D010879:Piperazines / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000627:therapeutic use*; D033581:Stem Cell Transplantation; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases